- Home
- FOSL vs VERU Comparison
FOSL vs VERU Comparison
Compare FOSL & VERU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOSL
- VERU
- Stock Information
- Founded
- FOSL 1984
- VERU 1971
- Country
- FOSL United States
- VERU United States
- Employees
- FOSL N/A
- VERU N/A
- Industry
- FOSL Consumer Specialties
- VERU Biotechnology: Pharmaceutical Preparations
- Sector
- FOSL Consumer Discretionary
- VERU Health Care
- Exchange
- FOSL Nasdaq
- VERU Nasdaq
- Market Cap
- FOSL 100.0M
- VERU 94.5M
- IPO Year
- FOSL 1993
- VERU 1990
- Fundamental
- Price
- FOSL $1.31
- VERU $0.58
- Analyst Decision
- FOSL
- VERU Strong Buy
- Analyst Count
- FOSL 0
- VERU 2
- Target Price
- FOSL N/A
- VERU $4.00
- AVG Volume (30 Days)
- FOSL 170.1K
- VERU 4.4M
- Earning Date
- FOSL 08-07-2025
- VERU 08-07-2025
- Dividend Yield
- FOSL N/A
- VERU N/A
- EPS Growth
- FOSL N/A
- VERU N/A
- EPS
- FOSL N/A
- VERU N/A
- Revenue
- FOSL $1,123,399,000.00
- VERU $16,886,419.00
- Revenue This Year
- FOSL N/A
- VERU N/A
- Revenue Next Year
- FOSL N/A
- VERU N/A
- P/E Ratio
- FOSL N/A
- VERU N/A
- Revenue Growth
- FOSL N/A
- VERU 134.43
- 52 Week Low
- FOSL $0.86
- VERU $0.45
- 52 Week High
- FOSL $2.61
- VERU $1.42
- Technical
- Relative Strength Index (RSI)
- FOSL 50.31
- VERU 52.23
- Support Level
- FOSL $1.30
- VERU $0.56
- Resistance Level
- FOSL $1.41
- VERU $0.74
- Average True Range (ATR)
- FOSL 0.08
- VERU 0.05
- MACD
- FOSL -0.02
- VERU -0.00
- Stochastic Oscillator
- FOSL 30.00
- VERU 36.26
About FOSL Fossil Group Inc.
Fossil Group Inc is a design, innovation and distribution company in consumer fashion accessories. The products include traditional watches, smartwatches, jewelry, handbags, small leather goods, belts and sunglasses. The reportable segments are comprised of 1) Americas segment includes sales in Canada, Latin America and the United States. 2) Europe segment includes sales in European countries, the Middle East and Africa. 3) Asia segment includes sales in Australia, China, India, Indonesia, Japan, Malaysia, New Zealand, Singapore, South Korea and Thailand. Each reportable operating segment includes sales to wholesale and distributor customers, and sales through Company-owned retail stores and e-commerce activities based on the location of the selling entity.
About VERU Veru Inc.
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.